Clinical Trial Update: Optimal Application Dose of Superficial Hyperthermia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the optimal application dose of superficial hyperthermia for tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumors

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Tumors | Phase 3 | Status: COMPLETED